Centauri Therapeutics Limited
PrivateLast Round
Series A
Extension
Feb 24, 2026
Total Funding Raised
$58.06M
Company Overview
Centauri Therapeutics Limited is a biotechnology company that develops novel immunotherapies for infectious diseases and oncology using its proprietary Alphamer platform technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Centauri Therapeutics Limited Comparables
Compare Centauri Therapeutics Limited with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Clarametyx Biosciences | 79% | |
| Infex Therapeutics | 77% | |
| Aurobac Therapeutics | 76% | |
Centauri Therapeutics Limited Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Feb 24, 2026 | ||||
| Grant | Jul 29, 2025 | ||||
| Grant | Nov 25, 2024 | ||||
| Grant | Feb 22, 2022 | ||||
| Series A | Feb 16, 2022 | ||||
Grant | Jan 7, 2020 |
Centauri Therapeutics Limited Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AMR Action Fund | Series A Extension |
| Boehringer Ingelheim | Series A Extension, Series A |
| PACE (Pathways to Antimicrobial Clinical Efficacy) | Grant |
| CARB-X | Series A Extension, Grant |
| Innovate UK | Grant |
| Medicines Discovery Catapult | Grant |
| Novo Holdings | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2025
$5.1M grant from CARB-X
- Jul 29, 2025
Developing ABX-01 programme, a broad-spectrum antimicrobial.
Centauri Therapeutics Limited Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Centauri Therapeutics Limited's valuation, stock price, and market status.